Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by bigwalleyeon Jun 29, 2010 12:45am
405 Views
Post# 17229523

RE: Loading UP

RE: Loading UPLike the saying goes, 'can a million flies be wrong?'  If SCT is done, why all the buyers?  This never happened with Nortel or other bricks I don't think.    Should I be throwing good money after bad and hope for the best?  What does everyone think is happening?

Maybe the big brains with deep pockets feel this is rock bottom and are averaging down to make back some of their lose?

sss - still on my radar just not in my portfolio
Bullboard Posts